POSTER PRESENTATIONS

1.

ZIKA VIRUS-LIKE PARTICLE AND SUBVIRAL PARTICLE VACCINES

Sandra R. Abbo, The Netherlands

2.

SEROPREVALENCE OF DENGUE, CHIKUNGUNYA AND ZIKA VIRUSES IN AN ANTENATAL POPULATION IN THE GREATER KINGSTON METROPOLITAN REGION OF JAMAICA

Joshua Anzinger, Jamaica

3.

DEVELOPMENT OF MOUSE AND NON-HUMAN PRIMATE MODELS FOR NON-CLINICAL IMMUNOGENICITY AND EFFICACY ASSESSMENT OF PURIFIED INACTIVATED ZIKA VACCINE

Marie Clotilde Bernard, France

4.

INTERIM MEASURE TO PREVENT ZKA VIRUS INFECTION IN PREGNANCY.

Subramaniam Ramasamy Chettiar, Malaysia

5.

COMPARISON OF VECTOR COMPETENCE OF AEDES ALBOPICTUS FOR CHIKUNGUNYA VIRUS ECSA STRAINS, WITH AND WITHOUT THE E1:A226V MUTATION, RESPONSIBLE FOR OUTBREAKS IN ITALY IN 2007 AND 2017, RESPECTIVELY

Claudia Fortuna, Italy

6.

CONGENITAL ZIKA VIRUS SYNDROME AMONG LIVE BIRTHS IN BRAZIL: A DESCRIPTION OF THE DISTRIBUTION OF REPORTED AND CONFIRMED CASES IN 2015-2016

Giovanny Vinicius Araujo Franca, Brazil

7.

ANALYSIS OF THE SERUM LIPID PROFILE IN ZIKA VIRUS INFECTION

Felipe Iani, Brazil

8.

CONGENITAL ZIKA SYNDROME AND OTHER BIRTH DEFECTS: EPIDEMIOLOGICAL AND CLINICAL FINDINGS

Felipe Iani, Brazil

9.

GENETIC EVIDENCE OF ZIKA VIRUS IN MOTHER'S BREAST MILK AND BODY FLUIDS OF A NEW-BORN WITH CONGENITAL DEFECTS

Felipe Iani, Brazil

10.

GENOMIC SURVEILLANCE OF CHIKUNGUNYA VIRUS FROM 2014 TO 2016 IN BAHIA, BRAZIL

Felipe Iani, Brazil

11.

SPATIAL DISTRIBUTION OF ZIKA VIRUS TRANSMISSION IN FEIRA DE SANTANA, BAHIA, BRAZIL

Felipe Iani, Brazil

12.

ZIKA VIRUS MOLECULAR DIAGNOSIS FROM DIFFERENT HUMAN BODY FLUIDS

Felipe Iani, Brazil

13.

RECOMBINANT BACULOVIRUS DELIVERING PRM/E GENES FOR EFFECTIVE IMMUNE RESPONSES AGAINST ZIKA VIRUS

Young Bong Kim, Republic of Korea

14.

NNOVATIVE APPLICATION TECHNOLOGY PROVEN TO BREAK DENV AND ZIKV TRANSMISSION – CURRENT STATUS

Heiko Kotter, France

15.

SPECIFICITY OF AN AUTOMATED ZIKA IGG IMMUNOASSAY IN THE DETECTION OF ZIKA-IGG SPECIFIC ANTIBODIES – A VALIDATION APPROACH IN SAMPLES FROM PREVALENCE AREAS AND NON-ENDEMIC COUNTRIES

Tina Laengin, Germany

16.

ILENT ENDEMIC CIRCULATION OF ROSS RIVER VIRUS IN THE PACIFIC ISLANDS AND RISK OF EMERGENCE IN OTHER TROPICAL AREAS

Didier Musso, French Polynesia

17.

SEVERE THROMBOCYTOPENIA IN ZIKA PATIENTS; AN OVERVIEW OF TREATMENT STRATEGIES AND OUTCOMES

Cornelis Adrianus De Pijper, The Netherlands

18.

SCREENING WITH THE SEROLOGICAL MULTIPLEX RECOMLINE TROPICAL FEVER IMMUNOBLOT IMPROVES THE DIFFERENTIATION OF ZIKV AND DENV INFECTIONS

Sarah Schulz, Germany

19.

NEGLECTED AUSTRALIAN ARBOVIRUSES ASSOCIATED WITH UNDIAGNOSED UNDIFFERENTIATED FEBRILE ILLNESS

Andrew Taylor Robinson, Australia

20.

PERCEPTIONS OF FAMILY PLANNING AND CONCERNS OF ADVERSE PREGNANCY OUTCOMES RELATED TO ZIKA VIRUS AMONG WOMEN IN COLOMBIA

Veronika Tirado, Sweden

21.

SPATIO-TEMPORAL PATTERN ANALYSIS OF SYMPTOMATIC ZIKA VIRUS INFECTION AMONG PREGNANT WOMEN IN CENTRAL PART OF BRAZIL, 2015-2017

Marilia Dalva Turchi, Brazil

22.

CONGENITAL ZIKA SYNDROME: ROLE OF SOCIOECONOMIC, ENVIRONMENTAL AND HEALTH INFLUENCE

Liana O. Ventura, Brazil

23.

OSU-03012 INHIBITS ZIKV REPLICATION BY TARGETING THE PAKT PATHWAY

Zheng Zhu, China